PMID- 19559728 OWN - NLM STAT- MEDLINE DCOM- 20091109 LR - 20131121 IS - 1879-0984 (Electronic) IS - 0166-0934 (Linking) VI - 161 IP - 2 DP - 2009 Nov TI - Detection and identification of U69 gene mutations encoded by ganciclovir-resistant human herpesvirus 6 using denaturing high-performance liquid chromatography. PG - 223-30 LID - 10.1016/j.jviromet.2009.06.016 [doi] AB - A denaturing high-performance liquid chromatography (dHPLC) assay was developed to detect antiviral drug-resistance mutations of human herpesvirus 6 (HHV-6). Recombinant baculoviruses were created that contained wild-type and mutant forms of the HHV-6 U69 gene, which determines sensitivity to the antiviral drug ganciclovir (GCV). The mutations causing GCV resistance in HHV-6 U69 were single-base mutations adapted from known GCV-resistant DNA sequences of HCMV, and their ability to confer GCV resistance on recombinant baculoviruses was confirmed. Six characterized mutant sequences, including one reported previously that encodes a GCV-sensitive kinase-activity mutant, were used. DNA was extracted, and the levels of homoduplex and heteroduplex DNA in the PCR products from mixed wild-type and mutant viral DNAs were determined using dHPLC. The optimized assay could distinguish the different mutants, and could detect mutants representing only 10% of the DNAs. The new assay with dHPLC readout permitted the rapid (4 h), objective, and reproducible detection of HHV-6 drug-resistance mutations. FAU - Nakano, Kazushi AU - Nakano K AD - Department of Infectious Disease Control, G-5, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan. FAU - Nishinaka, Kazuko AU - Nishinaka K FAU - Tanaka, Tatsuya AU - Tanaka T FAU - Ohshima, Atsushi AU - Ohshima A FAU - Sugimoto, Nakaba AU - Sugimoto N FAU - Isegawa, Yuji AU - Isegawa Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090625 PL - Netherlands TA - J Virol Methods JT - Journal of virological methods JID - 8005839 RN - 0 (Antiviral Agents) RN - 0 (DNA, Viral) RN - P9G3CKZ4P5 (Ganciclovir) SB - IM MH - Antiviral Agents/*therapeutic use MH - Base Sequence MH - Chromatography, High Pressure Liquid/methods MH - DNA, Viral/chemistry/genetics MH - Drug Resistance, Viral/*genetics MH - Ganciclovir/*therapeutic use MH - *Genes, Viral MH - Herpesvirus 6, Human/chemistry/drug effects/*genetics MH - Humans MH - Molecular Sequence Data MH - *Point Mutation MH - Reproducibility of Results MH - Roseolovirus Infections/drug therapy/*virology MH - Sensitivity and Specificity EDAT- 2009/06/30 09:00 MHDA- 2009/11/10 06:00 CRDT- 2009/06/30 09:00 PHST- 2009/02/24 00:00 [received] PHST- 2009/06/10 00:00 [revised] PHST- 2009/06/16 00:00 [accepted] PHST- 2009/06/30 09:00 [entrez] PHST- 2009/06/30 09:00 [pubmed] PHST- 2009/11/10 06:00 [medline] AID - S0166-0934(09)00301-2 [pii] AID - 10.1016/j.jviromet.2009.06.016 [doi] PST - ppublish SO - J Virol Methods. 2009 Nov;161(2):223-30. doi: 10.1016/j.jviromet.2009.06.016. Epub 2009 Jun 25.